Form 8-K - Current report:
SEC Accession No. 0001437749-25-021483
Filing Date
2025-06-30
Accepted
2025-06-30 08:04:19
Documents
14
Period of Report
2025-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250627_8k.htm   iXBRL 8-K 29083
2 EXHIBIT 99.1 ex_834925.htm EX-99.1 18272
  Complete submission text file 0001437749-25-021483.txt   204236

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250630.xsd EX-101.SCH 4113
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250630_def.xml EX-101.DEF 13904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250630_lab.xml EX-101.LAB 18374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250630_pre.xml EX-101.PRE 13936
16 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250627_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 251088804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)